Insupod 50 Dry Syrup contains Cefpodoxime Proxetil 50mg/5ml, a third-generation cephalosporin antibiotic with broad-spectrum activity against various Gram-positive and Gram-negative bacteria. It is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, otitis media, and pharyngitis caused by susceptible organisms. Cefpodoxime Proxetil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The dry syrup formulation is designed for pediatric patients who require an oral antibiotic with improved palatability and ease of administration. After reconstitution, Insupod 50 Dry Syrup should be stored as per guidelines and consumed within the prescribed duration to maintain efficacy. Dosage and duration depend on the infection severity, patient age, and weight, and should be strictly followed as per medical advice to prevent resistance development. Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions, including rash and anaphylaxis, though rare, require immediate medical attention. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Insupod 50 Dry Syrup is contraindicated in patients with known hypersensitivity to cefpodoxime or other cephalosporins. It is essential to complete the full course of therapy to ensure eradication of the infection and minimize resistance risk.